HES1 and colorectal carcinoma: Although Weng et al. found that high expression of HES1 mRNA correlated with poor prognosis6, Ahadi et al. used immunohistochemistry to demonstrate that loss of HES1 expression predicted worse prognoses in CRC patients7.